Known targets — ChEMBL curated mechanism
ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL21082705 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL10799939 | 1.00 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL4141332 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL19973172 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| SCHEMBL1884576 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL16416518 | 0.98 | LMNA (0.95) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL21082704 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| SCHEMBL1884574 | 0.98 | LMNA (0.87) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL25290978 | 0.95 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 | |
| Gluconic Acid SCHEMBL23415272 | 0.95 | LMNA (0.91) | LMNAPDE4AL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4905 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115820503-B | Preparation method of fecal bacteria for intestinal flora transplantation | 山东省大健康精准医疗产业技术研究院 | 2026-05-15 | — | — | CN | claimed |
| CN-122006785-A | Molecular sieve domain-limited metal propane dehydrogenation catalyst and preparation method and application thereof | 南开大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122012669-A | Reagent and kit for determining angiotensin converting enzyme and preparation method thereof | 中元汇吉生物技术股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4731736-A1 | COMPOSITION COMPRISING BIOSURFACTANT AND MANGANESE | Evonik Operations GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-3814303-B1 | NOVEL CROP NUTRITION AND FORTIFICATION COMPOSITION | SML LTD (IN) | 2026-04-29 | — | — | EP | claimed |
| US-20260077020-A1 | ORAL PEPTIDE PHARMACEUTICAL COMPOSITION THAT FACILITATES ENHANCED ORAL ABSORPTION | LE ROUX DANIELLE MARIE (US) | 2026-03-19 | — | — | US | claimed |
| WO-2026044339-A1 | METHODS FOR CAPTURING SULFUR DIOXIDE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-03-05 | — | — | WO | claimed |
| EP-4687872-A1 | ORAL ACTIVE INGREDIENT COMBINATION CONTAINING L-ARGININE, L-CITRULLINE, SELENITE AND WATER-SOLUBLE BORON | RFB HealthCare GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| US-20260028294-A1 | NOVEL CROP NUTRITION AND FORTIFICATION COMPOSITION | SML LIMITED (IN) | 2026-01-29 | — | — | US | claimed |
| EP-4676451-A1 | COMPOSITION COMPRISING MEDIUM-CHAIN TRIGLYCERIDES, OMEGA-3 AND CHOLINE FOR USE IN A METHOD OF TREATMENT OF COGNITIVE DECLINE AND DEMENTIA | Global Pharmacies Partner S.R.L. in Forma Abbreviata G.P.P. S.R.L. (IT) | 2026-01-14 | — | — | EP | claimed |
| US-5200211-A | Sorbitol, anti-urease component; suppression of appetite for food and alcohol | FOODSMITH CORPORATION (US) | 1993-04-06 | — | — | US | claimed |
| WO-1992021355-A1 | CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS | THE PROCTER & GAMBLE COMPANY (US) | 1992-12-10 | — | — | WO | claimed |
| EP-0514451-A1 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS. | UNIV TEXAS (US) | 1992-11-25 | — | — | EP | claimed |
| EP-0181342-B1 | METHOD OF TREATING HYPERTENSION IN VERTEBRATES | ERK, Vernon (US) | 1992-10-28 | — | — | EP | claimed |
| US-5151274-A | Calcium citrate malate for bone disorders | THE PROCTER & GAMBLE COMPANY (US) | 1992-09-29 | — | — | US | claimed |
| US-5098719-A | Compositions to alleviate malnutrition and suppress appetites in humans for ethanol or food | FOODSMITH CORPORATION (US) | 1992-03-24 | — | — | US | claimed |
| US-5075116-A | Composition and method for treatment of macular degeneration | LAHAYE LABORATORIES, INC. (US) | 1991-12-24 | — | — | US | claimed |
| WO-1991011117-A2 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-08-08 | — | — | WO | claimed |
| US-4497800-A | Stable liquid diet composition | MEAD JOHNSON & COMPANY (US) | 1985-02-05 | — | — | US | claimed |
| EP-0000968-B1 | A PHARMACEUTICAL COMPOSITION WITH AN ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTI-ASTHENIC EFFECT | Suck, Catherine Geneviève (FR) | 1981-10-14 | — | — | EP | claimed |